Laurel Hill, New Jersey - On Friday, InTest Corporation (NYSE: INTT) announced its Q4 earnings that exceeded analyst expectations, with adjusted earnings per share of $0.16, up $0.04 from the market consensus of $0.12.
Following the announcement, the company’s stock rose 0.60% in after-hours trading.
Revenue reached $32.8 million, surpassing the $31.6 million estimate, representing a 25.1% increase from the third quarter but a 10.3% decline from $36.6 million in the same period last year.
The company attributed the revenue rebound to gradual improvement in capital expenditures from most end-market customers and approximately $2 million of delayed shipments from Q3.
Gross margin expanded by 350 basis points quarter-over-quarter to 45.4%, driven by manufacturing efficiency improvements and favorable contributions from Alfamation’s new products.
Nearly 80% of revenue came from non-semiconductor end markets, reflecting the company’s diversification strategy.
President and CEO Nick Grant stated, “Revenue exceeded our guidance range and rebounded in Q4, reflecting the gradual recovery in customer capital spending we saw mid-year, especially in industrial and defense/aerospace end markets.”
For Q1 2026, InTest expects revenue of $31 million to $33 million, with a midpoint of $32 million, slightly above typical seasonal patterns.
For the full year 2026, the company projects revenue between $125 million and $130 million, with a midpoint of $127.5 million, exceeding analyst consensus of $124.9 million.
The company announced Q4 orders of $37.5 million, up 22.2% year-over-year, driven by continued strong performance in automotive/electric vehicle and life sciences markets. End-of-year backlog reached $53.9 million, a 36.4% increase from December 31, 2024.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
InTest's Q4 performance exceeded expectations, with revenue rebounding
Laurel Hill, New Jersey - On Friday, InTest Corporation (NYSE: INTT) announced its Q4 earnings that exceeded analyst expectations, with adjusted earnings per share of $0.16, up $0.04 from the market consensus of $0.12.
Following the announcement, the company’s stock rose 0.60% in after-hours trading.
Revenue reached $32.8 million, surpassing the $31.6 million estimate, representing a 25.1% increase from the third quarter but a 10.3% decline from $36.6 million in the same period last year.
The company attributed the revenue rebound to gradual improvement in capital expenditures from most end-market customers and approximately $2 million of delayed shipments from Q3.
Gross margin expanded by 350 basis points quarter-over-quarter to 45.4%, driven by manufacturing efficiency improvements and favorable contributions from Alfamation’s new products.
Nearly 80% of revenue came from non-semiconductor end markets, reflecting the company’s diversification strategy.
President and CEO Nick Grant stated, “Revenue exceeded our guidance range and rebounded in Q4, reflecting the gradual recovery in customer capital spending we saw mid-year, especially in industrial and defense/aerospace end markets.”
For Q1 2026, InTest expects revenue of $31 million to $33 million, with a midpoint of $32 million, slightly above typical seasonal patterns.
For the full year 2026, the company projects revenue between $125 million and $130 million, with a midpoint of $127.5 million, exceeding analyst consensus of $124.9 million.
The company announced Q4 orders of $37.5 million, up 22.2% year-over-year, driven by continued strong performance in automotive/electric vehicle and life sciences markets. End-of-year backlog reached $53.9 million, a 36.4% increase from December 31, 2024.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.